FindTrial
Sign In

Methylprednisolone (drug)

DRUG5 trials

Sponsors

University Hospital, Bordeaux, Mayo Clinic, Copenhagen Respiratory Research, Dr. Lutfi Kirdar Kartal Training and Research Hospital

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Community Acquired Pneumonia (CAP)IgA Nephropathy (IgAN)Multiple Sclerosis, Chronic ProgressiveSudden Sensorineural Hearing Loss

Phase 2

Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
RecruitingNCT06676579
Mayo ClinicIgA Nephropathy (IgAN)
Start: 2025-06-09End: 2029-03-02Target: 16Updated: 2025-10-03

Phase 3

Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis
CompletedNCT00241254
University Hospital, BordeauxMultiple Sclerosis, Chronic Progressive
Start: 2005-12-31End: 2012-03-31Updated: 2012-03-15

Phase 4

Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)
RecruitingNCT06892197
Copenhagen Respiratory ResearchCommunity Acquired Pneumonia (CAP)
Start: 2026-03-10End: 2030-11-01Target: 1600Updated: 2026-03-18
Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
RecruitingNCT06892210
Copenhagen Respiratory ResearchChronic Obstructive Pulmonary Disease (COPD)
Start: 2026-03-10End: 2030-11-01Target: 2000Updated: 2026-03-18
Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Sensorineural Hearing Loss
RecruitingNCT06968507
Dr. Lutfi Kirdar Kartal Training and Research HospitalSudden Sensorineural Hearing Loss
Start: 2025-05-20End: 2028-09-10Target: 214Updated: 2025-05-13

Related Papers

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis
PLoS ONE2017-01-0332 citations